Detection of +8 and 20q- in myelodysplastic syndrome patients by fluorescence in situ hybridization and cytogenetic analysis

Clinical Focus ›› 2012, Vol. 27 ›› Issue (9): 761-763.

Previous Articles Next Articles

Detection of +8 and 20q- in myelodysplastic syndrome patients by fluorescence in situ hybridization and cytogenetic analysis

TANG Yuan-yan;LIANG Yan;XIONG Tao;ZHANG Li-ming;YU Yong-zhi;HUANG Zhi-ping

Online:2012-05-05 Published:2012-05-05

Abstract

CLC Number:

R551.31

TANG Yuan-yan;LIANG Yan;XIONG Tao;ZHANG Li-ming;YU Yong-zhi;HUANG Zhi-ping. Detection of +8 and 20q- in myelodysplastic syndrome patients by fluorescence in situ hybridization and cytogenetic analysis[J]. Clinical Focus, 2012, 27(9): 761-763.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/

https://huicui.hebmu.edu.cn/EN/Y2012/V27/I9/761

[1]	. [J]. Clinical Focus, 2012, 27(19): 1731-1733.
[2]	. [J]. CLINICAL FOCUS, 2010, 25(7): 592-595.
[3]	. [J]. CLINICAL FOCUS, 2010, 25(4): 364-366.
[4]	WANG Dong-mei;GUO Hui-mei;WANG Jv-mei;SUN Guo-feng;GUO Xiao-ling;PAN Ling. Relationship between JAK2 V617F point mutation and clinical characteristics of BCR-ABL negative myeloproliferative diseases patients [J]. CLINICAL FOCUS, 2008, 23(5): 317-0.
[5]	. [J]. CLINICAL FOCUS, 2007, 22(14): 1054-1056.

Detection of +8 and 20q- in myelodysplastic syndrome patients by fluorescence in situ hybridization and cytogenetic analysis

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 5

Recommended Articles

Metrics

Comments